GlassScriptPhysician profile
Erika K Graul
NPI 1396881256
$8,186.10
in general payments reported to CMS, 2019-2025
37 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,545 · 2022: $1,555 · 2023: $1,528 · 2024: $1,667 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,824 · Education: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,824.38 |
| Education | $261.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,800.70 | 2021-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,035.65 | 2021-2025 | Airsupra, Breztri, Fasenra |
| Regeneron Healthcare Solutions, INC. | $828.44 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $785.37 | 2021-2025 | Ofev, Jascayd |
| Mylan Specialty L.P. | $720.99 | 2021-2024 | Yupelri |
| Genzyme Corporation | $536.53 | 2021-2025 | |
| Harmony Biosciences LLC | $331.57 | 2022-2025 | Wakix |
| United Therapeutics Corporation | $263.06 | 2021-2024 | Tyvaso |
| Insmed, INC. | $214.97 | 2023-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $195.52 | 2021-2025 | Glassia |
| Sanofi-Aventis U.S. LLC | $179.12 | 2021-2025 | |
| Viatris Specialty LLC | $168.96 | 2025 | Yupelri |
| Baxter Healthcare | $145.09 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $97.14 | 2021-2023 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $96.97 | 2023-2025 | Inspire |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $96.48 | 2021-2022 | |
| Axsome Therapeutics, INC. | $71.02 | 2023 | Sunosi |
| Verona Pharma, INC. | $68.53 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $50.72 | 2023 | Opsumit, Uptravi |
| Avadel Cns Pharmaceuticals, LLC | $49.42 | 2024-2025 | Lumryz |
| Teva Pharmaceuticals USA, INC. | $45.80 | 2021 | |
| Electromed, INC. | $41.50 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $40.34 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.72 | 2021-2023 | |
| Tactile Systems Technology INC | $32.48 | 2025 | Flexitouch Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $32.17 | 2021 | |
| Merck Sharp & Dohme LLC | $28.66 | 2023 | |
| Lilly USA, LLC | $28.28 | 2025 | Zepbound |
| Medtronic, INC. | $26.40 | 2025 | Illumisite |
| Philips North America LLC | $24.54 | 2021 | |
| Genentech USA, INC. | $20.20 | 2023 | Xolair |
| Pfizer INC. | $19.33 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $18.63 | 2021 | |
| Amgen INC. | $18.21 | 2024 | Tavneos |
| Breas Medical, INC. | $15.09 | 2023 | Vivo 45 Ls |
| Itamar Medical INC | $11.62 | 2021 | |
| 3b Medical, INC. | $6.88 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Graul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.